ProPhase Labs to license two investigational cancer compounds from Global BioLife
ProPhase Labs (PRPH) on Thursday said its unit had entered into a licensing agreement with Global BioLife for two inhibitors that can be used to treat multiple indications, with an…
ProPhase Labs to license two investigational cancer compounds from Global BioLife
ProPhase Labs (PRPH) on Thursday said its unit had entered into a licensing agreement with Global BioLife for two inhibitors that can be used to treat multiple indications, with an…